$2.75 Billion is the total value of NEA Management Company, LLC's 44 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 15.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSRO | TESARO INC | $1,437,077,000 | -9.1% | 10,275,113 | 0.0% | 52.29% | -4.9% | |
| MRSN | New | MERSANA THERAPEUTICS INC | $113,775,000 | – | 8,144,267 | +100.0% | 4.14% | – |
| AKAOQ | ACHAOGEN INC | $113,325,000 | -13.9% | 5,215,128 | 0.0% | 4.12% | -9.9% | |
| DERM | DERMIRA INC | $102,184,000 | -14.6% | 3,506,649 | 0.0% | 3.72% | -10.6% | |
| GLYC | GLYCOMIMETICS INC | $95,799,000 | +105.5% | 8,584,128 | 0.0% | 3.49% | +115.1% | |
| EPZM | EPIZYME INC | $94,539,000 | -12.0% | 6,260,851 | 0.0% | 3.44% | -7.9% | |
| ARDX | ARDELYX INC | $71,826,000 | -59.7% | 14,083,582 | 0.0% | 2.61% | -57.8% | |
| RARX | RA PHARMACEUTICALS INC | $65,471,000 | -12.0% | 3,493,636 | 0.0% | 2.38% | -7.9% | |
| SENS | Buy | SENSEONICS HOLDINGS INC | $60,165,000 | +27.8% | 33,425,275 | +27.1% | 2.19% | +33.6% |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCadr | $53,997,000 | -18.5% | 12,025,999 | 0.0% | 1.96% | -14.8% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $51,596,000 | -26.4% | 3,220,728 | 0.0% | 1.88% | -23.0% | |
| CRCM | CARE COM INC | $49,241,000 | +20.7% | 3,260,989 | 0.0% | 1.79% | +26.3% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $39,189,000 | +14.7% | 2,382,286 | 0.0% | 1.43% | +20.0% | |
| GRPN | Sell | GROUPON INC | $38,545,000 | -34.9% | 10,037,882 | -33.3% | 1.40% | -31.9% |
| TNTRQ | New | TINTRI INC | $38,192,000 | – | 5,253,358 | +100.0% | 1.39% | – |
| AVEO | AVEO PHARMACEUTICALS INC | $36,325,000 | +276.3% | 16,362,694 | 0.0% | 1.32% | +293.5% | |
| CASC | CASCADIAN THERAPEUTICS INC | $33,675,000 | -10.3% | 9,064,575 | 0.0% | 1.22% | -6.1% | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $29,610,000 | +50.5% | 4,141,308 | 0.0% | 1.08% | +57.5% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $29,476,000 | -16.5% | 4,808,483 | 0.0% | 1.07% | -12.7% | |
| OBSV | OBSEVA SA | $28,528,000 | -17.9% | 3,336,563 | 0.0% | 1.04% | -14.1% | |
| NVRO | NEVRO CORP | $26,771,000 | -20.6% | 359,678 | 0.0% | 0.97% | -16.9% | |
| PTI | PROTEOSTASIS THERAPEUTICS INC | $16,646,000 | -40.2% | 3,556,778 | 0.0% | 0.61% | -37.3% | |
| SNAP | New | SNAP INCcl a | $14,461,000 | – | 813,802 | +100.0% | 0.53% | – |
| SCMP | New | SUCAMPO PHARMACEUTICALS INCcl a | $13,214,000 | – | 1,258,507 | +100.0% | 0.48% | – |
| ELGX | ENDOLOGIX INC | $12,102,000 | -32.9% | 2,490,204 | 0.0% | 0.44% | -29.8% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $8,854,000 | -14.7% | 3,243,150 | 0.0% | 0.32% | -10.8% | |
| TRVN | TREVENA INC | $8,767,000 | -37.3% | 3,811,691 | 0.0% | 0.32% | -34.5% | |
| AFMD | AFFIMED NV | $7,972,000 | -10.9% | 3,888,888 | 0.0% | 0.29% | -6.8% | |
| VRNA | New | VERONA PHARMA PLCads | $7,770,000 | – | 666,666 | +100.0% | 0.28% | – |
| TCON | TRACON PHARMACEUTICALS INC | $6,622,000 | -36.0% | 2,759,217 | 0.0% | 0.24% | -33.1% | |
| DZSI | DASAN ZHONE SOLUTIONS INC | $5,738,000 | -3.9% | 956,255 | 0.0% | 0.21% | +0.5% | |
| HIVE | Sell | AEROHIVE NETWORKS INC | $5,605,000 | -69.1% | 1,121,080 | -74.0% | 0.20% | -67.7% |
| MIRN | MIRNA THERAPEUTICS INC | $4,968,000 | -23.7% | 2,974,811 | 0.0% | 0.18% | -20.3% | |
| New | TRILLIUM THERAPEUTICS INC | $4,619,000 | – | 1,050,000 | +100.0% | 0.17% | – | |
| CSBR | CHAMPIONS ONCOLOGY INC | $4,016,000 | -18.9% | 1,562,500 | 0.0% | 0.15% | -15.1% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $3,505,000 | -34.2% | 1,298,274 | 0.0% | 0.13% | -30.8% | |
| ABIO | ARCA BIOPHARMA INC | $3,505,000 | -5.9% | 1,460,209 | 0.0% | 0.13% | -1.5% | |
| ARQL | ARQULE INC | $3,125,000 | +17.0% | 2,520,316 | 0.0% | 0.11% | +22.6% | |
| ROKA | ROKA BIOSCIENCE INC | $2,306,000 | -27.5% | 893,471 | 0.0% | 0.08% | -24.3% | |
| AKTX | AKARI THERAPEUTICS PLCadr | $2,084,000 | -58.4% | 452,167 | 0.0% | 0.08% | -56.3% | |
| PRTK | PARATEK PHARMACEUTICALS INC | $1,597,000 | +25.3% | 66,245 | 0.0% | 0.06% | +31.8% | |
| OREXQ | OREXIGEN THERAPEUTICS INC | $1,076,000 | -15.7% | 370,900 | 0.0% | 0.04% | -11.4% | |
| CERC | CERECOR INC | $341,000 | -15.2% | 595,435 | 0.0% | 0.01% | -14.3% | |
| CBIO | CATALYST BIOSCIENCES INC | $202,000 | -50.7% | 43,492 | 0.0% | 0.01% | -50.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-07-26
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.